Blogs and opinion pieces on the trends and news in the retail pharmacy industry.
In his monthly column, David Orgel discusses the new retail imperative, which is to provide excitement and enhanced solutions — alongside safety — to customers.
In his monthly column, David Orgel looks at how tough times for consumers means retailers have an opportunity to strengthen their customer relationships by supporting shoppers.
In his latest column, David Orgel says that it’s time for retailers across food and drug to accelerate their capabilities with new investments and initiatives.
LexisNexis Risk Solutions' Craig Ford discusses the ways that pharmacists on the front lines of the COVID-19 pandemic have demonstrated everyday heroism.
Hamacher Resource Group's Dave Wendland highlights how taking a moment before reacting in times of stress can help reveal the best way to move forward.
CHPA's Scott Melville discusses how the organization is updating its branding to reflect its ongoing evolution as the industry grows and changes.
David Orgel discusses the opportunity retailers have to support consumer behaviors around health and nutrition that have changed as a result of the COVID-19 pandemic.
Dan Mack discusses how the COVID-19 pandemic has made speed, experimentation and agility imperatives for companies who want to succeed and deliver on customer expectations.
NACDS president and CEO Steve Anderson offers a statement on racism and discusses how the organization is committing itself to diversity and inclusion efforts to help members better serve their team members and communities.
Columnist David Orgel discusses the ways that COVID-19 has seen retailers hone their skills in crisis operations and why they must retain these capabilities for the future.
David Orgel discusses how the COVID-19 pandemic has created new preparedness imperatives within retail, as well as new ways of interacting with customers and communities.
Dan Ochwat examines how COVID-19 has led retailers and suppliers to get creative about connecting virtually in the wake of several postponed or canceled industry events.
Pharmacogenomics pharmacist Adrijana Kekic outlines what pharmacogenomics testing can mean for patients and pharmacy practice.
DSN editor in chief Seth Mendelson highlights how retailers are working to keep the in-store experience as painless as possible in trying times.